Education and Training
Emollient Therapy for Premature Infants in Zimbabwe
The purpose of this study is to assess the efficacy of topical emollient treatments in improving neonatal growth and mortality rates.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- other: Topical Emollient Therapy
Eligibility
Inclusion Criteria:
- infants <72 hours of age
- weigh 700-1500 at birth
- hospitalized at SMCH
Exclusion Criteria:
- infants who are moribund and highly likely not to survive despite any intervention
- significant breaches in their skin barrier
- conditions indicating failure to gain weight
- critically ill (definition below):
1. Oxygen saturation <88% on oxygen therapy AND ≥2 of the following conditions:
2. respiratory rate <20 or >100 breaths per minute
3. apnea requiring bag-mask ventilation
4. heart rate <100 or >200 beats per minute
- congenital syphilis
- hydrops fetalis
- a life-threatening congenital anomaly or major surgical condition requiring
intervention
- generalized skin disease or a structural defect involving >5% body surface area likely
to produce a defect in epidermal barrier function
Ages Eligible for Study
N/A - 28 Days
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Gary Darmstadt, MD, MS
650-724-6014
Not Recruiting